138 related articles for article (PubMed ID: 11282228)
1. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles.
Lippacher A; Müller RH; Mäder K
Int J Pharm; 2001 Feb; 214(1-2):9-12. PubMed ID: 11282228
[TBL] [Abstract][Full Text] [Related]
2. Liquid and semisolid SLN dispersions for topical application: rheological characterization.
Lippacher A; Müller RH; Mäder K
Eur J Pharm Biopharm; 2004 Nov; 58(3):561-7. PubMed ID: 15451530
[TBL] [Abstract][Full Text] [Related]
3. Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties.
Lippacher A; Müller RH; Mäder K
Eur J Pharm Biopharm; 2002 Mar; 53(2):155-60. PubMed ID: 11879997
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.
Souto EB; Wissing SA; Barbosa CM; Müller RH
Eur J Pharm Biopharm; 2004 Jul; 58(1):83-90. PubMed ID: 15207541
[TBL] [Abstract][Full Text] [Related]
5. Investigation on the viscoelastic properties of lipid based colloidal drug carriers.
Lippacher A; Müller RH; Mäder K
Int J Pharm; 2000 Mar; 196(2):227-30. PubMed ID: 10699724
[TBL] [Abstract][Full Text] [Related]
6. Development of etofenamate-loaded semisolid sln dispersions and evaluation of anti-inflammatory activity for topical application.
Badilli U; Sengel-Turk CT; Onay-Besikci A; Tarimci N
Curr Drug Deliv; 2015; 12(2):200-9. PubMed ID: 24925321
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of new and scalable topical formulations containing N-acetyl-d-glucosamine-loaded solid lipid nanoparticles.
Marto J; Sangalli C; Capra P; Perugini P; Ascenso A; Gonçalves L; Ribeiro H
Drug Dev Ind Pharm; 2017 Nov; 43(11):1792-1800. PubMed ID: 28581831
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
9. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents.
Souto EB; Müller RH
Pharmazie; 2006 May; 61(5):431-7. PubMed ID: 16724541
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A.
Pople PV; Singh KK
AAPS PharmSciTech; 2006; 7(4):91. PubMed ID: 17285742
[TBL] [Abstract][Full Text] [Related]
11. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams.
Souto EB; Müller RH
Pharmazie; 2007 Jul; 62(7):505-9. PubMed ID: 17718190
[TBL] [Abstract][Full Text] [Related]
12. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties.
Jenning V; Schäfer-Korting M; Gohla S
J Control Release; 2000 May; 66(2-3):115-26. PubMed ID: 10742573
[TBL] [Abstract][Full Text] [Related]
13. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
Silva AC; Santos D; Ferreira DC; Souto EB
Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
[TBL] [Abstract][Full Text] [Related]
14. Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations.
Souto EB; Wissing SA; Barbosa CM; Müller RH
J Cosmet Sci; 2004; 55(5):463-71. PubMed ID: 15608996
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Shirasu Porous Glass (SPG) membrane emulsification for the preparation of colloidal lipid drug carrier dispersions.
Joseph S; Bunjes H
Eur J Pharm Biopharm; 2014 May; 87(1):178-86. PubMed ID: 24333666
[TBL] [Abstract][Full Text] [Related]
16. Rheology of nanostructured lipid carriers (NLC) suspended in a viscoelastic medium.
Souto EB; Gohla SH; Müller RH
Pharmazie; 2005 Sep; 60(9):671-3. PubMed ID: 16222866
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles (SLN) for topical drug delivery: incorporation of the lipophilic drugs N,N-diethyl-m-toluamide and vitamin K.
Işcan Y; Wissing SA; Hekimoğlu S; Müller RH
Pharmazie; 2005 Dec; 60(12):905-9. PubMed ID: 16398266
[TBL] [Abstract][Full Text] [Related]
19. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite.
Hamishehkar H; Shokri J; Fallahi S; Jahangiri A; Ghanbarzadeh S; Kouhsoltani M
Drug Dev Ind Pharm; 2015; 41(10):1640-6. PubMed ID: 25382163
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
